Following graduation from the University of California at Berkeley and the Albert Einstein College of Medicine, Dr. Wu was a post-doctoral fellow and Lecturer in the Department of Zoology at the University of California at Berkeley. Prior to joining the federal government in 1979, he worked for a biotech company as a Senior Scientist for 5 years. In 1986 after working for 7 years in the Laboratory of Molecular Pharmacology of the NCI’s intramural program, More…
The Clinical Grants and Contracts Branch (CGCB) manage a multidisciplinary research portfolio which includes translational research grants and cooperative agreements. The CGCB portfolio is concentrated in the areas of clinical oncology, surgical oncology, cancer nutrition and pharmacogenomics. These program areas are focused on the development of investigative clinical agents, related correlative studies, novel treatment regimens, and clinical and surgical methods development.
CGCB program staff participates in the planning, implementation and management of the Clinical Trials Cooperative Groups and other clinical consortia engaged in evaluating novel modalities for cancer treatment and management. CGCB program staff participates in extramural policy solicitation, formulation and budget development and assist with the management of the CTEP-sponsored clinical trials portfolio.
CGCB Program Directors (PDs) manage the scientific, technical, administrative and fiscal aspects of CTEP's extramural clinical research portfolio. PDs are responsible for, but are not limited to, the following activities:
Referral guidelines for the three grant programs can be found at: